Recent data highlight TAVR’s long-term durability: What cardiologists need to know

The Sapien 3 Ultra Resilia TAVR valve. Images courtesy of Edwards Lifesciences.

The Sapien 3 Ultra RESILIA transcatheter heart valve. Image courtesy of Edwards Lifesciences. 

Andy Morse, MD, the director of valvular and structural heart disease at Ascension Saint Thomas Hospital West in Nashville, leads a team that has performed more than 4,000 TAVR procedures. He spoke to Cardiovascular Business about recent findings on the long-term performance of the balloon-expandable SAPIEN 3™ platform.